The world is not enough - the value of increasing registry data in idiopathic pulmonary fibrosis

被引：3
作者：
Moor, C. C. [1 ]
Kreuter, M. [2 ,3 ]
Luppi, F. [4 ]
Wuyts, W. A. [5 ]
机构：
[1] Erasmus MC, Dept Resp Med, Rotterdam, Netherlands
[2] Heidelberg Univ, Ctr Interstitial & Rare Lung Dis Pneumol & Resp C, Thoraxklin, Heidelberg, Germany
[3] German Ctr Lung Res, Heidelberg, Germany
[4] Univ Milano Bicocca, Resp Unit, S Gerardo Hosp, Monza, Italy
[5] Univ Hosp Leuven, Dept Resp Med, Leuven, Belgium
来源：
RESPIRATORY RESEARCH | 2020年 / 21卷 / 01期
关键词：
PIRFENIDONE; NINTEDANIB; DIAGNOSIS; CAPACITY; OUTCOMES; SAFETY;
D O I：
10.1186/s12931-020-01377-1
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
    Jo, Helen E.
    Glaspole, Ian
    Grainge, Christopher
    Goh, Nicole
    Hopkins, Peter M. A.
    Moodley, Yuben
    Reynolds, Paul N.
    Chapman, Sally
    Walters, E. Haydn
    Zappala, Christopher
    Allan, Heather
    Keir, Gregory J.
    Hayen, Andrew
    Cooper, Wendy A.
    Mahar, Annabelle M.
    Ellis, Samantha
    Macansh, Sacha
    Corte, Tamera J.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (02)
  • [2] Real-World Data on the Course of Idiopathic Pulmonary Fibrosis
    Nathan, Steven D.
    Lee, Joyce S.
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (07) : S107 - S113
  • [3] Longitudinal clinical outcomes in a real-world population of patients with idiopathic pulmonary fibrosis: the PROOF registry
    Wuyts, Wim A.
    Dahlqvist, Caroline
    Slabbynck, Hans
    Schlesser, Marc
    Gusbin, Natacha
    Compere, Christophe
    Maddens, Sofie
    Lee, Yuan-Chi
    Kirchgaessler, Klaus-Uwe
    Bartley, Karen
    Bondue, Benjamin
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [4] Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Brunnemer, Eva
    Waelscher, Julia
    Tenenbaum, Svenja
    Hausmanns, Julia
    Schulze, Karen
    Seiter, Marianne
    Heussel, Claus Peter
    Warth, Arne
    Herth, Felix J. F.
    Kreuter, Michael
    RESPIRATION, 2018, 95 (05) : 301 - 309
  • [5] Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis Data from the IPF-PRO Registry
    Salisbury, Margaret L.
    Conoscenti, Craig S.
    Culver, Daniel A.
    Yow, Eric
    Neely, Megan L.
    Bender, Shaun
    Hartmann, Nadine
    Palmer, Scott M.
    Leonard, Thomas B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (11) : 1413 - 1423
  • [6] Current and Novel Treatment Modalities of Idiopathic Pulmonary Fibrosis
    Arshad, Mahnoor
    Athar, Zoraize Moeez
    Hiba, Tasneem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [7] Insights into idiopathic pulmonary fibrosis in the real world
    Cottin, Vincent
    Wuyts, Wim
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (01) : 16 - 18
  • [8] Antifibrotic treatment of idiopathic pulmonary fibrosis
    Markart, P.
    Drakopanagiotakis, F.
    Wygrecka, M.
    PNEUMOLOGE, 2020, 17 (03): : 177 - 185
  • [9] Idiopathic pulmonary fibrosis
    Leon-Roman, Francisco
    Valenzuela, Claudia
    Molina-Molina, Maria
    MEDICINA CLINICA, 2022, 159 (04): : 189 - 194
  • [10] Idiopathic pulmonary fibrosis
    Xaubet, Antoni
    Ancochea, Julio
    Molina-Molina, Maria
    MEDICINA CLINICA, 2017, 148 (04): : 170 - 175
12345